Cargando…

Safety-Related Drug Withdrawals in China Between 1999 and 2021: A Systematic Investigation and Analysis

INTRODUCTION: The Chinese National Medical Products Administration (NMPA) has emphasized proactive pharmacovigilance throughout the product life cycle in recent years. However, the safety-related withdrawal of drugs from the Chinese market has received less attention. OBJECTIVES: The primary aim of...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yanrong, Jiang, Yang, Wang, Haixue, Zhang, Li, Yang, Yue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296427/
https://www.ncbi.nlm.nih.gov/pubmed/35821561
http://dx.doi.org/10.1007/s40264-022-01185-0